Skip to content
Review Open access

High Mortality in Adults With Community-Acquired Pneumonia Admitted to Hospitals in South Africa Before and During the COVID-19 Pandemic, Stratified by HIV Serostatus and Viral Load: Data From a Prospective Cohort Study (2019–2021)

Sep 2026 · Open Forum Infectious Diseases · Vol 13 · 0 citations · 30 references
Medicine

TL;DR

In-hospital and postdischarge community-acquired pneumonia mortality remains high, particularly among PWH, regardless of virologic status, warranting urgent investigation of mitigation strategies.

Abstract

Abstract Background Community-acquired pneumonia (CAP) is a leading cause of death in adults, but recent data in people with HIV (PWH) are lacking. We studied South African adults hospitalized with CAP to describe mortality and risk factors. Methods We prospectively enrolled consenting adults aged ≥18 years hospitalized with CAP, as defined by symptoms, signs, and chest x-ray, from March 2019 to October 2021 in 3 South African hospitals. Blood, sputum, nasopharyngeal/oropharyngeal swabs, and urine were tested for HIV, tuberculosis, SARS-CoV-2, influenza, respiratory syncytial virus, and Streptococcus pneumoniae. Participants were followed for 1 year. Causes of death were defined following record review. Timing and risk factors for death were evaluated by Kaplan-Meier and Cox analyses. Results Of 2000 adults (median age, 46 years), 1079 (54.0%) were PWH. Among 994 with HIV viral load results, 289 (29.1%) were virally suppressed, and among 1556 tested for SARS-CoV-2, 700 (45.0%) were positive. There were 569 (28.5%) deaths, and the majority died early: 47.7% during hospitalization and 10.6% ≤30 days postdischarge. Leading underlying causes of death were COVID-19 (23.0%), tuberculosis (16.9%), and advanced HIV (13.2%). Age ≥45 years (hazard ratio, 2.7; 95% CI, 1.5–4.6), active tuberculosis (1.6, 1.2–2.0), unsuppressed HIV viral load (1.4, 1.0–1.9), anemia (1.3, 1.0–1.6), underweight (1.3, 1.0–1.7), and low admission oxygen saturation (<94% on room air; 1.3, 1.0–1.6) were associated with mortality. Mortality was higher in PWH (18.2 vs 11.7 per 100 person-years) but similar between PWH who were virally suppressed and unsuppressed (21.3 vs 24.7 per 100 person-years). Conclusions In-hospital and postdischarge CAP mortality remains high, particularly among PWH, regardless of virologic status, warranting urgent investigation of mitigation strategies.

Read PDF

Similar papers

Open access Oct 2026

Prevalence of chronic kidney disease among patients co-infected with COVID-19 and HIV at the University of Ilorin Teaching Hospital, Ilorin, Nigeria: a cross-sectional study

Coronavirus disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), remains a significant global health challenge. People living with HIV (PLHIV) may face an elevated risk of severe complications, particularly those with low CD4 counts, high viral loads, advanced clinical...

Blessing Iveren Olusanjo, Mariam Kehinde Sulaiman, T. Olanrewaju et al. · 0 citations
Open access Sep 2026

Molecular Etiology and Mortality Risk Stratification of Non-SARS-CoV-2 Severe Acute Respiratory Infection in a Predominantly Pediatric Cohort: A Retrospective Study From a Tertiary Care Hospital in North India

Background: Severe acute respiratory infections (SARI) remain a major cause of hospitalization and mortality, particularly among children and other vulnerable populations. Early identification of pathogens and disease severity is essential for clinical decision-making. This study evaluated the etiology of non-SARS-CoV-...

P. Garg, V. Dutta, Mohit Bhatia et al. · 0 citations
Open access Sep 2026

FACTORS ASSOCIATED WITH IN-HOSPITAL DEATH AMONG PATIENTS WITH SEVERE ACUTE RESPIRATORY SYNDROME AND VIRAL CODETECTION IN BRAZIL: A RETROSPECTIVE COHORT STUDY WITH MULTIVARIABLE ANALYSIS, 2022–2023

Objective: To identify demographic, clinical, healthcare, and virological factors associated with in-hospital death among patients with severe acute respiratory syndrome (SARS) and respiratory viral codetection in Brazil. Methods: We conducted a retrospective cohort study using 2022–2023 records from the Brazilian Infl...

Daniele Melo Sardinha, Francilene Nazaré Barros de Souza, Jucinete Pinheiro de Moraes Guimarães et al. · 0 citations
Open access Sep 2026

Characteristics and outcomes of adult patients hospitalised with RSV infection, influenza or COVID-19 in Belgium, winter seasons 2023/24 and 2024/25

Patients with RSV infection had a disease course comparable to patients with influenza or COVID-19 and a higher mortality rate, especially with increasing age, highlighting the importance of RSV vaccination in older adults and those with comorbidities, alongside established vaccination strategies for seasonal influenza...

Y. Lafort, Cato Dambre, Y. Dockx et al. · 0 citations
Open access Oct 2026

Epidemiological, Clinical and Laboratory Characteristics of Hospitalized Children with SARS-CoV-2 Infection During Three Consecutive Pandemic Years: A Retrospective Cohort Study

Background: Coronavirus disease 2019 (COVID-19) generally follows a milder clinical course in children than in adults. The clinical characteristics of pediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have evolved throughout the pandemic and longitudinal data comparing successive pandemic...

Ioana Maria Otilia Lică, I. Țincu, A. Drăgănescu et al. · 0 citations
Open access Sep 2026

Community-acquired Haemophilus influenzae pneumonia in people living with HIV: a 30-year propensity score–matched cohort study

To compare the clinical characteristics, management, and outcomes of community-acquired pneumonia (CAP) caused by Haemophilus influenzae in people living with HIV (PWH) versus HIV-negative patients, and to evaluate whether HIV infection independently influences disease severity, intensive care unit (ICU) admission, or...

C. Cillóniz, Antonio Campanella, R. Guglielmi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.